2023
DOI: 10.1039/d3cb00145h
|View full text |Cite
|
Sign up to set email alerts
|

Copper binding and protein aggregation: a journey from the brain to the human lens

Yanahi Posadas,
Carolina Sánchez-López,
Liliana Quintanar

Abstract: Metal ions have been implicated in several proteinopathies associated to degenerative and neurodegenerative diseases. While the molecular mechanisms for protein aggregation are still under investigation, recent findings from CryoEM point...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(8 citation statements)
references
References 103 publications
0
0
0
Order By: Relevance
“…This is different from the formation of fibril when γD-Crystallin is exposed to UV−C light. 5 ANS binding studies were carried out to get more details about the effect of Cu (II) on γD-Crystallin. A globular protein has hydrophobic regions buried deep inside a folded state.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…This is different from the formation of fibril when γD-Crystallin is exposed to UV−C light. 5 ANS binding studies were carried out to get more details about the effect of Cu (II) on γD-Crystallin. A globular protein has hydrophobic regions buried deep inside a folded state.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
“…Our earlier results have shown that encapsulation of quercetin increases its shelf life. 5 To further confirm that quercetin-loaded nanocarriers can act as inhibitors, TEM was employed. The TEM micrographs in the So far, it could be concluded that metal ions like Cu (II) bind with γD-Crystallin.…”
Section: ■ Results and Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Although the protective effect of Cu(II) on amyloid aggregation of both pathogenic and nonpathogenic proteins has been reported, Cu(II) is also known to promote amyloid formation of different proteins. For example, several research studies suggest that Cu(II) ions can enhance the amyloid aggregation of Aβ 1–40 , immunoglobulin G (IgG), and BSA . However, the inhibitory effect of Cu(II) ion has also been established against the aggregation of several pathogenic proteins and peptides including amylin, Aβ 1–16 , Aβ 1–42 , and γD-crystalline. Although an altered level of Cu(II) has been reported in the brains of AD patients which can directly influence senile plaque deposition and neuronal loss, as well as neuroinflammation, a direct link between copper and the neurotoxicity in AD is largely unexplored. Some studies have shown Cu(II) deficiency in the pathogenesis of AD, while other reports have revealed increased Cu(II) content .…”
mentioning
confidence: 99%